)
)
111 Investor Relations Material
Latest events
Fireside Chat
111
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from 111 Inc
Access all reports
111, Inc. operates as a digital healthcare platform in China, focusing on connecting patients with pharmaceutical products and healthcare services through both online and offline channels. The company operates in two main segments: B2C (business-to-consumer) and B2B (business-to-business). The B2C segment includes online retail of prescription and over-the-counter drugs, nutritional supplements, medical supplies, and personal care products. The B2B segment involves an online wholesale pharmacy platform that serves other pharmacies and healthcare providers. Additionally, 111, Inc. offers online consultation, electronic prescription services, and patient management services through its internet hospital. Headquartered in Shanghai, 111, Inc.'s shares are listed on the NASDAQ.
Key slides for 111 Inc
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
YI
Country
🇺🇸 United States